Inside the Triple Helix: Technology Transfer And Commercialization In The Life Sciences

The transfer and subsequent application of academic research results has demonstrable benefits for health care, researchers, universities, companies, and local economies. Nonetheless, at least three general concerns exist: bias in the reporting of results, limited revenues from these activities, and...

Full description

Saved in:
Bibliographic Details
Published inHealth Affairs Vol. 23; no. 1; pp. 64 - 76
Main Authors Campbell, Eric G, Powers, Joshua B, Blumenthal, David, Biles, Brian
Format Journal Article
LanguageEnglish
Published United States Health Affairs 01.01.2004
The People to People Health Foundation, Inc., Project HOPE
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The transfer and subsequent application of academic research results has demonstrable benefits for health care, researchers, universities, companies, and local economies. Nonetheless, at least three general concerns exist: bias in the reporting of results, limited revenues from these activities, and the lack of data to evaluate technology transfer activities. Future efforts with regard to technology transfer in the life sciences will need to recognize its importance without ignoring concerns or overestimating benefits. Next steps include better monitoring of university-industry relationships, the development of a better data system, the dissemination of best practices in technology transfer management, and evaluation of national technology-transfer policies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0278-2715
1544-5208
DOI:10.1377/hlthaff.23.1.64